Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?
Noemí Güemes-Villahoz(Hospital Clínico San Carlos), Barbara Burgos‐Blasco(University of British Columbia), Alberto Delgado‐Iribarren(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Pedro Arriola‐Villalobos(Universidad Complutense de Madrid), Carla Rico-Luna(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Ana Arribi‐Vilela(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Ricardo Cuiña‐Sardiña(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos)
Cited by 81
Related Papers
Conjunctivitis in COVID-19 patients: frequency and clinical presentation
|Graefe s Archive for Clinical and Experimental Ophthalmology|2020|86
Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea
|Acta Ophthalmologica|2021|68
Tear and aqueous humour cytokine profile in primary open‐angle glaucoma
|Acta Ophthalmologica|2020|62
Topical insulin for refractory persistent corneal epithelial defects
|European Journal of Ophthalmology|2020|59
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia
|Clinical Microbiology and Infection|2016|57